ANI Pharmaceuticals Q1 2026 Earnings Strong EPS Beat Highlights Operational Strength SY Q1 2026 Earnings NarrowerThanExpected Loss Fails to Lift Sentiment as Shares Decline 165 EXP Q1 2026 Earnings Powerful EPS Beat Highlights Cost Discipline Amid Subdued Demand BMRA Q1 2026 Earnings Biomerica Reports Net Loss of 044 Per Share Amid Ongoing Development Efforts BZFD Q1 2026 Earnings WiderThanExpected Loss Sends Shares Higher on Strategic Progress MAXN Q4 2024 Earnings NarrowerThanExpected Loss Highlights Cost Discipline Amid Solar Industry Headwinds